Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background: We investigated the differential effects of serotonergic and noradrenergic antidepressants on brain activation in patients with major depressive disorder during a Stroop task. We predicted that pretreatment hyperactivity in the rostral anterior cingulate cortex would predict better treatment outcomes. Methods: In total, 20 patients underwent naturalistic open-label clinical treatment with citalopram ( n = 12) or reboxetine ( n = 8). We performed functional magnetic resonance imaging at baseline and after 6 weeks of treatment. Results: There were no significant group differences in clinical characteristics, treatment outcomes or baseline fMRI activations. The group by time interaction revealed significant voxels in the right amygdala–hippocampus complex ( p < 0.05, family-wise error corrected by use of the bilateral amygdala and hippocampus mask image as a small volume), indicating a posttreatment blood oxygen level–dependent signal decrease in the citalopram group. Pretreatment hyperactivity in the rostral anterior cingulate cortex was not related to symptom improvement. Limitations: Our study was a nonrandomized clinical trial. Conclusion: These results indicate that serotonergic and noradrenergic antidepressants have a differential effect on brain activity, especially in the amygdala and hippocampus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Although optimized treatment strategies, including numerous modern antidepressants, have recently been developed, fewer than 50% of patients with MDD show full remission.(2,3) Motivated by these data, a growing number of neuroimaging studies have focused on the prediction of response to antidepressant treatment and th…”
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“A network comprised mainly of the limbic, frontal and cingulate regions has been shown to be altered with regard to function and brain structure in this disorder.(1) Although optimized treatment strategies, including numerous modern antidepressants, have recently been developed, fewer than 50% of patients with MDD sho…”
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848 · cited 2×
“In the reboxetine group, only a reduction in the middle temporal gyrus could be observed, which potentially reflects a phasic effect of increased availability of noradrenaline on the ventral pathways of visual processing in the Stroop task, as reported in previous studies.(15) The noradrenergic and serotonergic pathwa…”
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“Although optimized treatment strategies, including numerous modern antidepressants, have recently been developed, fewer than 50% of patients with MDD show full remission.(2,3) Motivated by these data, a growing number of neuroimaging studies have focused on the prediction of response to antidepressant treatment and th…”
Sheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., & Mintun, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01263-x · Cited by 1,191 · cited 1×
“Previous studies that investigated the effect of SSRIs on brain activity in patients with MDD reported, in agreement with our data, a reduction in resting state metabolism(4,5) or a reduced capacity for activation in terms of BOLD signal in the hippocampus and amygdala during affective processing.(11,26) The independe…”
The cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182 · cited 1×
“Therefore, an ongoing effect of antidepressants even after discontinuation could not be entirely ruled out, particularly in light of the long-term downstream adaptive processes on pre- and postsynaptic receptors and of changes in the intracellular signaling pathways.(39) To exclude any potential long-term effects of a…”
Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115
Fu, C. H. Y., Williams, S. C. R., Cleare, A. J., Brammer, M. J., Walsh, N. D., Kim, J., Andrew, C. M., Pich, E. M., Williams, P. M., Reed, L. J., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.9.877 · Cited by 775
Kennedy, S. H., Evans, K. R., Krüger, S., Mayberg, H. S., Meyer, J. H., McCann, S., Arifuzzman, A. I., Houle, S., & Vaccarino, F. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.899 · Cited by 710 · cited 3×
“, variation from 6 weeks to 4–6 months of treatment) and antidepressants, which varied from tricycle medication to SSRIs and bupropion.(5,12,13,25,36) Furthermore, we predominantly investigated female patients in contrast to predominantly or solely male patients as in other studies.”
Cited by
Fu, C. H. Y., Steiner, H., & Costafreda, S. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.008 · Cited by 399
“…al., 2011; Fu et al., 2008a, 2008b; Konarski et al., 2009; Langenecker et al., 2007; Little et al., 1996, 2005; Marquand et al., 2008; Milak et al., 2009; Ritchey et al., 2011; Roy et al., 2010; Samson et al., 2011; Saxena et al., 2003; Siegle et al., 2006; Wagner et al., 2010; Walsh et al., 2007).”
BackgroundApplication of functional near-infrared spectroscopy in psychiatry
Ehlis, A.-C., Schneider, S., Dresler, T., & Fallgatter, A. J. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.03.067 · Cited by 292
McCabe, C., & Mishor, Z. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.051 · Cited by 184
Neuroimaging-based biomarkers for treatment selection in major depressive disorder
Dunlop, B. W., & Mayberg, H. S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/bdunlop · Cited by 127
Marsh, R., Horga, G., Parashar, N., Wang, Z., Peterson, B. S., & Simpson, H. B. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.004 · Cited by 79
Metadata
- Authors
- Wagner, G., Koch, K., Schachtzabel, C., Sobanski, T., Reichenbach, J. R., Sauer, H., & Schlösser, R. G. M.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2010-07
- Volume
- 35
- Issue
- 4
- Pages
- 247-257
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W1996172063
- Cited by
- 81
- References
- 19
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. https://app.cochat.ai/papers/10.1139/jpn.090081
- The paper
- Wagner, G., Koch, K., Schachtzabel, C., Sobanski, T., Reichenbach, J. R., Sauer, H., & Schlösser, R. G. M. (2010). Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.090081
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.